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Introduction
The syncytial myofi  ber is the functional unit of skeletal muscle. 
As with many other adult tissues, skeletal muscle contains resi-
dent stem cells, termed satellite cells because of their location on 
the periphery of myofi  bers under the surrounding basal lamina 
(Mauro, 1961; for review see Zammit and Beauchamp, 2001). 
Satellite cells proliferate to provide myonuclei to growing myofi  -
bers before becoming quiescent in mature muscle (Schultz et al., 
1978). Fulfi   llment of satellite cell functions of maintenance, 
  hypertrophy, and repair requires that they fi  rst be activated to enter 
the cell cycle and produce large numbers of myoblast progeny. 
Most of these subsequently differentiate and either fuse with ex-
isting myofi  bers or form new myotubes (Snow, 1978), but others 
adopt an alternative fate and self-  renew to maintain the satellite 
cell pool (Zammit et al. 2004; Collins et al., 2005).
What controls the crucial transition of satellite cells from 
quiescence to proliferation remains largely unknown. Various 
stimuli released from crushed myofi   bers, invading macro-
phages, and connective tissue have been proposed to trigger 
satellite cell activation (for review see Chargé and Rudnicki, 
2004). One of these signals is hepatocyte growth factor 
(HGF; Tatsumi et al., 1998), and members of the FGF family have 
also been proposed to recruit satellite cells to division (Bischoff, 
1986; Yablonka-Reuveni et al., 1999). Because the receptors for 
both HGF (c-met) and FGF are members of the tyrosine kinase 
family of receptors, attention has been directed toward classical 
kinase-mediated signaling in control of satellite cell activation 
(Yablonka-Reuveni et al., 1999; Shefer et al., 2001; Jones et al., 
2005) and proliferation in myogenic cells (Jones et al., 2001; 
Tortorella et al., 2001).
Over the last few years, the importance of sphingolipid 
signaling has begun to be understood (for review see   Spiegel 
and Milstien, 2003). Sphingosine-1-phosphate (S1P) and ho-
mologous phosphorylated long-chain sphingoids act in diverse 
organisms such as mammals, worms, fl  ies, slime mold, yeast, 
and plants. In mammals, S1P is mitogenic for several cell types, 
including fi  broblasts and endothelial cells (Zhang et al., 1991; 
Olivera and Spiegel, 1993; Olivera et al., 1999). In addition to 
this role in cell division and survival, S1P is involved in pro-
cesses such as calcium homeostasis and cell migration during 
angiogenesis and cardiac development, as well as in the adult 
immune system (for review see Spiegel and Milstien, 2003). 
In contrast, other sphingolipids such as ceramide and sphingo-
sine are associated with cell growth   arrest, stress responses, and 
apoptosis (for review see Hannun and Obeid, 2002).
Recent studies have revealed that sphingolipids are also 
active in muscle. Defects in muscle development and integrity 
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dult skeletal muscle is able to repeatedly regen-
erate because of the presence of satellite cells, 
a population of stem cells resident beneath the 
basal lamina that surrounds each myoﬁ  ber. Little is known, 
however, of the signaling pathways involved in the activation 
of satellite cells from quiescence to proliferation, a crucial 
step in muscle regeneration. We show that sphingosine-
1-phosphate induces satellite cells to enter the cell cycle. 
Indeed, inhibiting the sphingolipid-signaling cascade that 
generates sphingosine-1-phosphate signiﬁ  cantly reduces 
the number of satellite cells able to proliferate in response 
to mitogen stimulation in vitro and perturbs muscle regen-
eration in vivo. In addition, metabolism of   sphingomyelin 
located in the inner leaﬂ   et of the plasma membrane is 
probably the main source of sphingosine-1-phosphate 
used to mediate the mitogenic signal. Together, our obser-
vations show that sphingolipid signaling is involved in the 
induction of proliferation in an adult stem cell and a key 
component of muscle regeneration.
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in Drosophila melanogaster are observed when the level of S1P 
is perturbed by targeted deletion of S1P lyase, an enzyme re-
sponsible for the irreversible degradation of S1P (Herr et al., 
2003). Sphingosine can also affect muscle contraction by mod-
ulating the function of certain calcium channels (for review see 
Sabbadini et al., 1999), whereas ceramide has an inhibitory ef-
fect on insulin-like growth factor I–induced protein synthesis in 
mouse myogenic C2C12 cells (Strle et al., 2004). S1P affects 
Ca
2+ homeostasis and cytoskeletal rearrangement (Formigli 
et al., 2002) in C2 cells and stimulates differentiation in this cell 
line (Donati et al., 2005).
Sphingomyelin is a precursor of ceramide, sphingosine, 
and S1P, which are all components of the same metabolic pathway
(Fig. 1). Sphingomyelin is one of the major lipid components 
of cell membranes in animals, with signifi  cant amounts in the 
plasma membrane (for review see van Meer and Holthuis, 
2000). Although the location of sphingomyelin used to generate 
signaling molecules such as S1P is unclear, the inner leafl  et of 
the plasma membrane has been suggested as a source (Kent 
et al., 1974; Linardic and Hannun, 1994; Andrieu et al., 1996; 
Zhang et al., 1997).
We have recently demonstrated the presence of high 
  concentrations of sphingomyelin in the plasma membrane of 
quiescent, but not proliferating, satellite cells (Nagata et al., 2006). 
Here, we focus on the role of S1P as a novel regulator of sat-
ellite cells and muscle regeneration. S1P can induce satellite 
cells to enter the cell cycle, whereas inhibiting the sphingolipid 
signaling cascade that generates S1P signifi  cantly reduces the 
number of satellite cells able to divide in response to mitogen 
stimulation. Sphingomyelin is hydrolyzed by neutral sphingo-
myelinase (N-SMase) and can then be further metabolized to 
S1P, to mediate the mitogenic signal. By use of a novel combi-
nation of the sphingomyelin binding protein lysenin (Sekizawa 
et al. 1997; Yamaji et al. 1998; Kobayashi et al., 2004) as a 
cytochemical probe, together with selective sphingomyelin di-
gestion, we demonstrate that the main source of S1P is sphingo-
myelin located in the inner leafl  et of the plasma membrane. 
Crucially, inhibiting S1P production after muscle damage 
greatly perturbs subsequent muscle regeneration. Together, our 
observations show the central role that sphingolipid signaling 
plays in mediating the entry of satellite cells into the cell cycle 
and muscle regeneration.
Results
We initially used the reserve cell model to investigate the role 
of lipid signaling pathways in myogenic cell activation, be-
fore examining its role in primary satellite cells and muscle 
regeneration in vivo. The kinetics of myogenesis in mouse C2 
cells is well defi  ned (Yablonka-Reuveni and Rivera, 1997). 
When C2 cells are cultured in mitogen-poor conditions, the 
majority differentiate and fuse to form multinucleated myo-
tubes. Some, however, stop dividing, down-regulate MyoD, 
and escape immediate differentiation to form reserve cells, 
but retain the ability to reenter the cell cycle when stimulated, 
thus providing a model of myogenic cell activation (Yoshida 
et al., 1998).
Myogenic reserve cells can be stimulated 
to divide by S1P
Proliferating C2C12 cells were switched to DME containing 1% 
horse serum for 5 d, after which few cells incorporated BrdU 
(0.9 ± 1.4%; Fig. 2 a). To fi  rst determine whether lipid signaling 
was involved in reserve cell activation, 10 μM S1P was added to 
differentiation medium on day 5 for 24 h, which resulted in an 
approximately sevenfold increase in the number of reserve cells 
entering the cell cycle (Fig. 2 a). The use of defi  ned medium 
has previously been used to analyze satellite cell activation 
(Yablonka-Reuveni and Rivera, 1994). To deplete lipids in the 
culture medium, FCS was incubated with charcoal (Lee et al., 
1998). Incubation with the charcoal-stripped FCS (CFCS) 
  resulted in an increase of  10-fold in BrdU incorporation, but 
addition of 2–10 μM S1P further increased the number of cells 
synthesizing DNA, in a dose-dependent manner (Fig. 2 a). When 
cycling C2C12 cells were switched to differentiation medium, 
the level of BrdU incorporation dropped signifi  cantly, and the 
presence of 1–10 μM S1P made no difference (Fig. 2 b). The 
ability of these cells to differentiate in response to serum with-
drawal was similarly unaffected by S1P (Fig. 2 c), consistent 
with a recent study (Donati et al., 2005). Therefore, S1P is im-
portant for entry of myogenic cells into the cell cycle but does 
not maintain division or prevent differentiation in the absence of 
other mitogens. In contrast, lysophosphatidic acid did not in-
duce reserve cells to proliferate (unpublished data), but this lipid 
did perpetuate cell division (Fig. 2 b) and inhibit differentiation 
(Fig. 2 c) when serum was withdrawn (Yoshida et al., 1996).
Figure 1.  Simpliﬁ  ed overview of sphingolipid metabolism. De novo syn-
thesis of sphingolipids begins with the serine palmitoyltransferase catalyzed 
condensation of serine with palmitoyl CoA. The resulting 3-  ketosphinganine 
is reduced to sphinganine and then subsequently acylated to form 
  dihydroceramide by ceramide synthase (inhibited by FB1). Ceramide is 
then produced from dihydroceramide by the insertion of the trans 4,5 dou-
ble bond by a desaturase. Ceramide can be reversibly converted to either 
sphingomyelin by sphingomyelin synthase or deacylated to sphingosine by 
ceramidase. S1P is then generated from sphingosine by the phosphoryla-
tion of the primary hydroxyl group by sphingosine kinase (inhibited by 
DMS). Sphingomyelin can act as a reservoir for sphingolipids and can be 
cleaved to ceramide by sphingomyelinase (inhibited by GW4869). S1P 
degradation is mediated by either the reversible dephosphorylation back 
to sphingosine by speciﬁ  c S1P phosphatases or the irreversible degrada-
tion by S1P lyase to hexadecenal and phosphorylethanolamine.SPHINGOLIPID SIGNALING IN SATELLITE CELL PROLIFERATION • NAGATA ET AL. 247
S1P production is required for reserve 
cells to enter the cell cycle
The cellular level of S1P is low and controlled by the balance 
between synthesis and degradation (Fig. 1). S1P is generated 
from sphingosine by phosphorylation of the primary hydroxyl 
group by sphingosine kinase. To examine the role of S1P in myo-
genic activation, we fi  rst blocked its synthesis from sphingosine 
using N,N-dimethylsphingosine (DMS; Yatomi et al., 1996; 
  Edsall et al., 1998), which inhibits both mammalian isozymes 
of sphingosine kinase. BrdU incorporation by reserve cells in 
response to CFCS was inhibited by DMS in a dose-  dependent 
manner, such that  50% failed to enter the cell cycle in the 
presence of 10 μM DMS (Fig. 3 a). Importantly, addition of 10 μM 
S1P counteracted the inhibitory effect of the highest concentra-
tion of DMS (Fig. 3 a), demonstrating that the reduction in the 
number of cells incorporating BrdU arose specifi  cally from the 
block on S1P generation and that restoration of S1P levels was 
suffi  cient to stimulate division.
Sphingomyelin is the origin of sphingosine 
for mediating reserve cell proliferation
We next examined the mechanism of generation of sphingosine 
in reserve cells in response to CFCS stimulation. Sphingosine 
is produced by deacylation of ceramide by ceramidase (Fig. 1). 
We used pharmacological inhibitors to target the two main 
sources of ceramide, namely, sphingomyelin cleavage by sphingo-
myelinases and de novo formation from sphinganine by cer-
amide synthase (Fig. 1). N-SMase is a regulator of lipid signaling 
(for review see Levade and Jaffrezou, 1999) and is specifi  cally 
inhibited by GW4869 (Luberto et al., 2002). Incorporation of 
BrdU by reserve cells in response to CFCS stimulation was as 
effectively diminished by GW4869 as by DMS (Fig. 3 b). This 
was again counteracted by addition of S1P, indicating that the 
inhibition was specifi  c to S1P production and was not signifi  -
cantly affecting other signaling pathways (Fig. 3 b). Therefore, 
inhibiting the metabolic pathway responsible for generating 
S1P at two separate steps resulted in a similar reduction in the 
number of cells entering the cell cycle.
Synthesis of ceramide by the de novo pathway was not 
a major source of S1P because the ceramide synthase inhibitor 
fumonisin B1 (FB1; Merrill et al., 1996) had no effect on the 
number of reserve cells induced to incorporate BrdU in response 
to CFCS exposure (Fig. 3 c). Moreover, when reserve cells were 
exposed to both FB1 and GW4869 before CFCS stimulation, 
the proportion of reserve cells induced to synthesize DNA was 
reduced to the same level as with GW4869 alone (unpublished 
data). This indicates that S1P synthesis from sphingomyelin, 
not prevention of S1P degradation to ceramide, was the pre-
dominant pathway responsible for induction of cell division. 
Collectively, these results demonstrate that reserve cell activa-
tion requires the cleavage of sphingomyelin to ultimately pro-
duce S1P, which mediates the mitogenic signal.
Separate visualization of sphingomyelin 
in the outer and inner leaﬂ  et 
of the plasma membrane
Sphingomyelin is predominantly distributed at the outer leafl  et 
of the plasma membrane (Koval and Pagano, 1991), but a dis-
tinct signaling pool has been postulated to be located in the in-
ner leafl  et (Linardic and Hannun, 1994; Andrieu et al., 1996; 
Zhang et al., 1997). Because the recently cloned N-SMase2 
  locates to the plasma membrane (Hofmann et al., 2000; 
  Karakashian et al., 2004), it is possible that most stimulus-
  induced sphingomyelin degradation is processed at this site.
Figure 2.  Exogenous S1P can directly induce DNA synthesis in quiescent 
myogenic cells. In the absence of serum stimulation, only  1% of reserve 
cells incorporate BrdU, but the addition of 10 μM S1P increases the num-
ber of dividing cells approximately sevenfold (a). The addition of 0.5% 
CFCS also stimulates cell division, but the proportion of cells incorporating 
BrdU is signiﬁ  cantly increased by S1P in a dose-dependent manner (a). 
To determine whether S1P also perpetuated proliferation in a manner similar 
to other lipids, such as lysophosphatidic acid (LPA), proliferating C2C12 
cells were switched to differentiation medium containing 0–10 μM S1P or 
30 μM LPA and cultured with daily medium changes for 3 d. After a 3-h 
BrdU pulse, either cells were immunostained for BrdU (b) or the percentage 
of nuclei incorporated in myotubes was determined (fusion index; c). S1P 
was unable to perpetuate division after mitogen withdrawal or prevent 
  differentiation, in contrast to LPA. Data presented are the mean percentage 
± SEM from four independent experiments. Asterisks indicate that data are 
statistically signiﬁ  cant using a t test (P < 0.01).JCB • VOLUME 174 • NUMBER 2 • 2006  248
To directly investigate the dynamics of sphingomyelin 
levels in individual reserve cells, we used the sphingomyelin-
specifi   c binding protein lysenin as a cytochemical marker 
(Sekizawa et al., 1997; Yamaji et al., 1998; Kobayashi et al., 
2004) in combination with selective sphingomyelin digestion 
by bacterial sphingomyelinase (bSMase; Fig. 4 a). As we 
showed previously (Nagata et al., 2006), when reserve cells 
are fi  xed/permeabilized with 4% PFA (Sugii et al., 2003), in-
cubated with 0.2 or 10 μg/ml lysenin, and immunostained using 
lysenin-specifi  c antisera, the surface of most reserve cells is 
strongly labeled, revealing high levels of sphingomyelin in the 
plasma membrane (Fig. 4 b). Complete loss of such lysenin 
  immunostaining after incubation of fi  xed/permeabilized cells in 
100 mU/ml bSMase confi  rms that binding of lysenin to sphingo-
myelin is specifi  c (Fig. 4 c). However, when live reserve cells 
were incubated for 2 h in bSMase, to prevent the enzyme from 
entering the cells, subsequent fi  xation/permeabilization before 
probing with lysenin revealed that sphingomyelin had been pro-
tected in the inner leafl  et under the entire cell surface (Fig. 4 d). 
Such inner leafl  et staining required 10 μg/ml lysenin, though, 
suggesting that there was a lower concentration of sphingo-
myelin in the inner leafl  et than in the outer leafl  et of the plasma 
membrane. In this way, the combination of digestion of specifi  c 
sphingomyelin pools and probing with lysenin permits us to 
Figure 3.  S1P is generated from sphingomyelin. 
When reserve cells were pretreated with 
DMS to inhibit sphingosine kinase activity be-
fore stimulation with 2% CFCS and pulsed with 
BrdU, the proportion of proliferating cells was 
signiﬁ  cantly reduced, indicating that S1P was 
being produced from sphingosine during entry 
to the cell cycle (a). 10 μM S1P overcame the 
DMS-induced block on S1P synthesis and re-
stored proliferation, showing that the DMS was 
speciﬁ  cally inhibiting sphingosine kinases (a). 
Sphingosine is derived from ceramide, of which 
there are two main sources, sphingo  myelin 
cleavage by SMases or de novo formation 
(Fig. 1). Reserve cells were treated with 
GW4869 for 45 min to inhibit the N-SMase 
catalyzed synthesis from sphingomyelin and 
then stimulated with 2% CFCS and pulsed with BrdU. Immunostaining for BrdU showed that the number of proliferating cells was signiﬁ  cantly reduced after 
GW4869 treatment (b). The inhibition by GW4869 was speciﬁ  c to the generation of S1P, as S1P overcame the block (b). In contrast, blocking de novo 
synthesis of ceramide by inhibiting ceramide synthase with FB1 had no effect on reserve cell activation (c). Mean percentage ± SEM of BrdU-positive cells 
per total mononucleated cells from four independent experiments. Asterisks indicate that data are statistically signiﬁ  cant using a t test (P < 0.05).
Figure 4.  Sphingomyelin in the inner leaﬂ  et 
of the plasma membrane is the source of S1P. 
The dynamics of sphingomyelin during reserve 
cell activation was examined using bSMase to 
selectively remove sphingomyelin from either 
the outer or inner leaﬂ   et while monitoring 
sphingomyelin levels with lysenin (a). Reserve 
cells were ﬁ  xed/permeabilized with 4% PFA, 
probed with 0.2 μg/ml lysenin, and immuno-
stained (green), and all nuclei were identiﬁ  ed 
using DAPI (blue). The vast majority of reserve 
cells bound lysenin, showing sphingomyelin 
on their surface (b). When reserve cells were 
ﬁ   xed/permeabilized and then treated with 
100 mU/ml bSMase to digest sphingomyelin 
on both the outer and inner leaﬂ  et,  sphingo-
myelin was no longer detectable (c). To distin-
guish between sphingomyelin on the inner and 
outer surfaces of the cell membrane, live re-
serve cells were treated with bSMase so that 
only external sphingomyelin was accessible to 
digestion. Lysenin (10 μg/ml) binding then re-
vealed sphingomyelin located only in the inner 
leaﬂ  et (d). To determine whether sphingo  myelin 
in the outer leaﬂ  et was metabolized to generate S1P, reserve cells were activated with 2% CFCS and either ﬁ  xed/permeabilized immediately (e) or after 
10 (f) or 30 min (g). No change in lysenin immunostaining was observed (e–g). To speciﬁ  cally assay sphingomyelin in the inner leaﬂ  et, live reserve cells 
were incubated with bSMase for 2 h to digest sphingomyelin in the outer leaﬂ  et before activation with 2% CFCS. Cells were then ﬁ  xed/permeabilized, 
probed with lysenin, and immunostained immediately (h) or after 10 (i) or 30 min (j) of stimulation. There was a transient drop in the number of reserve 
cells with lysenin immunostaining after 10 min of stimulation (i, quantiﬁ  ed in k [closed squares]), whereas unstimulated reserve cells exhibited no such drop 
(k, open squares). Live reserve cells treated with bSMase for 2 h and then incubated with 20 μM GW4869 before activation with 2% CFCS (l) showed 
that inhibition of N-SMase prevented the transient loss of sphingomyelin in the inner leaﬂ  et by blocking its cleavage (l, open circles). Data were obtained 
from three independent experiments and are expressed as mean percentage ± SEM of lysenin-positive cells per total mononucleated cells. Bar: (b–d) 
50 μm; (e–j) 100 μm.SPHINGOLIPID SIGNALING IN SATELLITE CELL PROLIFERATION • NAGATA ET AL. 249
  visualize, for the fi  rst time, two distinct pools of sphingomyelin 
in reserve cells, one located in the outer leafl  et of the plasma 
membrane on the cell surface and a second on the inside of the 
cell in the inner leafl  et (Fig. 4, a–d).
Sphingomyelin in the inner leaﬂ  et 
of the plasma membrane is metabolized 
to generate S1P
The ability to separately visualize these two pools of sphingo-
myelin at the plasma membrane enabled us to determine which 
was involved in the lipid-signaling cascade controlling reserve 
cell activation. Sphingomyelin turnover in response to extra-
cellular stimuli is usually rapid: N-SMase catalyzed sphingo-
myelin cleavage, occurring within 10 min (Andrieu-Abadie and 
Levade, 2002). To explore this event, sphingomyelin levels were 
monitored in reserve cells for 30 min after stimulation with 
CFCS. No changes in overall lysenin immunostaining were 
  observed, indicating that sphingomyelin on the cell surface 
  remained constant (Fig. 4, e–g).
Detection of changes of sphingomyelin content of the inner 
leafl  et, however, would be masked by the stable amounts in the 
outer leafl  et of the plasma membrane, which we were able to 
eliminate by incubation of live reserve cells with bSMase for 2 h 
before stimulation with CFCS. Such removal of sphingomyelin 
solely from the outer leafl  et of the plasma membrane did not 
  prevent cell cycle entry, as these cells incorporated BrdU as 
 effi  ciently as untreated cells (unpublished data). After 10 min of 
CFCS stimulation, however, a marked drop was found in the 
  proportion of cells with high inner leafl  et sphingomyelin levels, 
which largely recovered by 30 min (Fig. 4, h–k). This transient 
decrease in sphingomyelin in the inner leafl  et during activation 
(Fig. 4, h–k) was prevented by the addition of GW4869 (Fig. 4 l). 
This shows that the fall in sphingomyelin levels at the inner leaf-
let of the plasma membrane in response to CFCS stimulation is 
caused by the cleavage of sphingomyelin by N-SMase. Because 
GW4869 signifi  cantly reduces the number of cells entering the 
cell cycle after stimulation (Fig. 3 b), this shows that sphingo-
myelin in the inner leafl  et is a major source of mitogenic S1P.
Entry of satellite cells into the cell cycle 
requires sphingolipid signaling
Having established that S1P signaling plays a role in the induc-
tion of proliferation in C2 reserve cells, we next investigated 
the relevance of this pathway in primary satellite cells. Viable 
myofi  bers can be isolated from muscle, complete with their reti-
nue of quiescent satellite cells (Rosenblatt et al., 1995). If these 
myofi  bers are not exposed to mitogens and are maintained in 
basal medium (e.g., DME/BSA), then the vast majority of satel-
lite cells do not enter the cell cycle. When these myofi  bers are 
cultured in mitogen-rich medium, however, their associated sat-
ellite cells proliferate and then differentiate, modeling the early 
events of muscle regeneration (Yablonka-Reuveni and Rivera, 
1994; Beauchamp et al., 2000; Zammit et al., 2004).
To determine whether exposure to S1P can directly elicit 
proliferation in satellite cells, myofi  bers were cultured in either 
DME/BSA (Fig. 5, a–c) or DME/BSA/1 μM S1P (Fig. 5, d–f) 
plus BrdU for 48 h. Coimmunostaining for Pax7 (Seale et al., 2000) 
and BrdU (Fig. 5, d–f) or proliferating cell nuclear antigen 
(PCNA) and MyoD (Fig. 5, g–j) showed that S1P signifi  cantly 
increased the number of satellite cells entering the cell cycle.
Generation of S1P is central 
to the induction of satellite cell proliferation
To examine whether S1P was generated as part of the response 
of satellite cells to mitogen stimulation, we again used the 
Figure 5.  S1P is required for inducing entry of satellite cells into the cell 
cycle. Isolated myoﬁ  bers were cultured in DME/BSA (a–c) or DME/BSA/
1 μM S1P (d–f) in the presence of BrdU. Myoﬁ  bers were ﬁ  xed 48 h later, 
and their associated satellite cells were coimmunostained for Pax7 (red) 
and BrdU (green; arrowheads in a–f). Similarly, immunostaining for MyoD 
(red) and PCNA (green; arrowheads in g–i) showed that there were signiﬁ  -
cantly more satellite cells entering the cell cycle in the presence of S1P than 
in DME/BSA (j). All nuclei present were identiﬁ  ed with DAPI (c, f, and i). 
Bar, 50 μm. To determine whether S1P is generated in response to mitogen 
stimulation during satellite cell activation, isolated myoﬁ  bers were treated 
with 10 μM DMS in DME for 45 min before their associated satellite cells were 
stimulated with CEE/serum and analyzed for the expression of PCNA (k). 
In the absence of DMS, satellite cells were readily activated and practically 
all entered the cell cycle, but after exposure to the inhibitor, signiﬁ  cantly 
less did so (k). To determine whether sphingomyelin was the source of S1P, 
isolated myoﬁ   bers were incubated with 10 μM GW4869 to inhibit 
N-SMase activity before mitogen stimulation and then immunostained. 
Again, there was a signiﬁ  cant reduction in the number of satellite cells en-
tering the cell cycle (k), showing that S1P is derived from sphingomyelin. 
Data represent the mean ± SEM of immunostained cells per myoﬁ  ber from 
three independent experiments (20 myoﬁ  bers per experiment). Asterisks in-
dicate that data are statistically signiﬁ  cant using a t test (P < 0.05).JCB • VOLUME 174 • NUMBER 2 • 2006  250
sphingosine synthase inhibitor DMS. Myofi  bers and their asso-
ciated satellite cells were immunostained with Pax7 to identify 
the total number of satellite cells present. Others were stimu-
lated with serum/chick embryo extract for 24 h and then immuno-
stained for PCNA, which showed that virtually all satellite 
cells had entered the cell cycle. However, when myofi  bers were 
stimulated in the presence of 10 μm DMS, the number of 
PCNA-positive satellite cells was reduced by  50% (Fig. 5 k).
To examine whether the ultimate source of S1P was sphin-
gomyelin, we again applied GW4869 to suspensions of iso-
lated myofi  bers and associated satellite cells stimulated with 
serum/chick embryo extract. Specifi  c inhibition of N-SMase 
with GW4869 (Luberto et al., 2002) again reduced the number 
of dividing PCNA-positive cells by  50% (Fig. 5 k), confi  rm-
ing that entry into cell cycle is mediated by S1P generated 
from sphingomyelin.
Inhibition of sphingolipid signaling perturbs 
muscle regeneration
Having established that sphingolipid signaling is involved in the 
induction of proliferation in satellite cells in vitro, we tested 
whether muscle regeneration in vivo was affected by inhibition 
of this pathway. Muscle damage was induced by injection of 
cardiotoxin into both tibialis anterior (TA) muscles of adult 
mice, and DMS was administered to the right TA to inhibit 
sphingosine kinase and, thus, S1P production, with the left 
  serving as a control. 7 d later, the muscles were removed, cryo-
sectioned, and either stained with hematoxylin and eosin or 
  immunostained for embryonic myosin heavy chain (eMyHC). 
Control muscles contained numerous nascent myotubes identi-
fi  ed by central nucleation and expression of eMyHC (Fig. 6, 
a and c). In contrast, muscles forced to regenerate in the presence 
of DMS to inhibit S1P production showed poor repair with 
fewer myotubes (Fig. 6, b and d). Quantifi  cation of the area of 
muscle occupied by regenerating myofi  bers showed that the 
presence of the sphingosine kinase inhibitor signifi  cantly re-
duced the amount of regenerated muscle (Fig. 6 e).
Together, these observations show that S1P signaling is 
clearly involved in muscle regeneration. Although administra-
tion of this pharmacological inhibitor may not only have af-
fected S1P synthesis in satellite cells, the resulting perturbation 
in myofi  ber regeneration is consistent with the observations 
that inhibiting the generation of S1P signifi  cantly reduces the 
number of satellite cells able to enter the cell cycle in response 
to stimulation in vitro (Fig. 5).
Discussion
Precise control of skeletal muscle size, along with rapid and 
  appropriate repair and maintenance, is predominantly a function 
of the satellite cell population and demands a well-controlled 
transition between quiescence and proliferation. Although sev-
eral factors involved in this process during muscle regeneration 
have been described, the process is far from fully understood 
(for review see Chargé and Rudnicki, 2004). Here, we show that 
this mitogenic signal is in part mediated in satellite cells by the 
cleavage of sphingomyelin at the inner leafl  et of the plasma 
membrane that is ultimately metabolized to generate S1P, which 
in turn stimulates entry into the cell cycle. As would be expected 
from these observations, inhibition of S1P synthesis perturbs 
muscle regeneration in vivo.
S1P can function in two ways: either as an agonist for 
specifi  c cell surface receptors or as a second messenger. S1P 
was shown to be a ligand for the EDG-1 (S1P1) receptor (Lee 
et al., 1998) and is now recognized as an agonist for fi  ve (S1P1 
through S1P5) G-protein–coupled cell surface receptors. S1P1 
through S1P5 are coupled to different G-proteins and so the rel-
ative abundance of specifi  c receptors and G-proteins allows S1P 
to have heterogeneous effects. The C2 myogenic cell line was 
originally derived from regenerating adult muscle (Yaffe and 
Saxel, 1977) and has been shown to express S1P1 through S1P3 
(Meacci et al., 1999). S1P, acting through S1P2, induces a small 
decrease in the number of cells proliferating in response to se-
rum and stimulates the appearance of proteins associated with 
differentiation (Donati et al., 2005). Our results are consistent 
with those of Donati et al. (2005) where they overlap because, 
in our hands, S1P did not prevent differentiation in cycling 
C2C12 cells, but we did not determine whether it actively pro-
moted it. Although the S1P receptors present on satellite cells 
Figure 6.  Inhibition of S1P synthesis perturbs muscle regeneration. 
TA muscles were induced to regenerate by injection of cardiotoxin together 
with India ink to mark the injection site. At the same time, the right TA mus-
cle was also injected with DMS to inhibit sphingosine kinase activity, thus 
preventing S1P synthesis. The left TA muscle served as a control, and only 
carrier DMSO was injected. 7 d later, both muscles were removed, cryo-
sectioned, and analyzed. Hematoxylin and eosin staining showed that 
control left TA muscles had regenerated successfully (a), with many large 
new myoﬁ  bers identiﬁ  ed by the central location of their myonuclei, in the 
vicinity of the injection site, as shown by the presence of the black India ink 
(a, top right). In contrast, even 7 d after injection, right TA muscles in which 
DMS had been administered exhibited severely retarded regeneration (b). 
To quantify regenerated muscle, sections were immunostained for eMyHC 
to identify new myoﬁ  bers (c and d) in the vicinity of the injection site (c’ and 
d’ bright ﬁ  eld image included to show location of India ink). The area oc-
cupied by regenerating myoﬁ  bers was determined from several such ex-
periments, and data were pooled and expressed as a percentage ± SEM 
of the total area assayed (e). This showed that administration of DMS re-
sulted in signiﬁ  cantly less regenerating myoﬁ  bers. Asterisks indicate that 
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are presently unknown, analysis has shown that S1P3 mRNA is 
present in quiescent satellite cells, but the levels are dramati-
cally lower in dividing cells (Montarras, D., and Buckingham, M., 
personal communication). Intriguingly, overexpression of 
S1P3 in cycling C2C12 cells suppresses markers of myogenic 
differentiation elicited by S1P (Donati et al., 2005).
S1P has also been implicated as a second messenger for 
cell growth and survival independently of its receptors (Olivera 
and Spiegel 1993; Van Brocklyn et al., 1998; Olivera et al., 
2003). For example, it has recently been shown that VEGF 
binding to VEGF receptor 2 stimulates endothelial cell growth 
through protein kinase C, which leads to the activation of sphingo-
sine kinase 1 and the generation of S1P. The extracellular 
  signal–regulated kinase (ERK)–MAPK pathway is then acti-
vated by S1P, resulting in cell division (Shu et al., 2002). 
  Because HGF also binds a tyrosine kinase type receptor, it is 
possible that the activation of sphingosine kinase 1 and subse-
quent production of S1P may also stimulate ERK–MAPK, 
  already shown to be involved in satellite cell activation 
(Yablonka-Reuveni et al., 1999; Shefer et al., 2001; Jones et al., 
2005). In addition to HGF (Tatsumi et al., 1998), TNF-α has re-
cently been proposed to be able to activate satellite cells, as sys-
temically delivered TNF-α enhances BrdU incorporation into 
skeletal muscles, presumably by the intermediary of satellite 
cells (Li, 2003). Although TNF-α can work through serum 
  response factor, it also activates sphingolipid signaling in 
  various cell types and induces sphingomyelin cleavage (Levade 
and   Jaffrezou, 1999; Spiegel and Milstien, 2003). Therefore, 
lipid signaling may act as a second messenger or via receptor-
  mediated pathways, or a combination of the two, in induction of 
satellite cell proliferation.
In contrast to the mitogenic effects of S1P, ceramide is as-
sociated with cell growth arrest, stress responses, and apoptosis 
in several cell types (for review see Hannun and Obeid, 2002). 
In muscle, ceramide has been shown to suppress the hyper-
trophic effects of insulin-like growth factor I (Strle et al., 2004) 
as well as that of insulin in C2C12 cells (Schmitz-Peiffer et al., 
1999). As it has been proposed that the relative levels of these 
interconvertible metabolites can determine cell fate (Spiegel 
and Milstien, 2003), it is possible that S1P and ceramide also 
exert contrary effects in satellite cells. Higher ceramide levels 
may be involved in the maintenance of satellite cell quiescence, 
whereas increasing S1P levels would act to overcome this block, 
inducing activation and subsequent proliferation.
Although both DMS and GW4869 effectively reduce the 
mitogenic effect of serum, neither of them was able to totally 
prevent the activation of all myogenic cells. There is increasing 
evidence that satellite cells may represent a heterogeneous 
  population (Beauchamp et al., 2000), so it is possible that they 
have different requirements for sphingolipid signaling. Another 
possible explanation is that the pharmacological inhibitors do 
not completely block the target enzyme, which would have a 
signifi  cant infl  uence when the ratio of S1P to ceramide, rather 
than their absolute amounts, is proposed to be the crucial factor 
in the cellular response (Spiegel and Milstien, 2003). It is also 
probable that there are other pathways that control satellite cells 
in addition to S1P-mediated signaling (Shefer et al., 2001; Jones 
et al., 2005) and that signal redundancy and cross talk between 
pathways may reduce the effects of specifi  cally inhibiting a par-
ticular signaling route.
Sphingolipid metabolites can be generated from two main 
sources: de novo synthesis of ceramide or cleavage of sphingo-
myelin. The site of the subcellular pool of sphingomyelin that is 
used for signaling, however, is unclear. Although sphingomyelin 
is mostly located at the outer leafl  et of the plasma membrane 
(Koval and Pagano, 1991), several lines of evidence suggest that 
there is a distinct pool of signaling sphingomyelin in the inner 
leafl  et, which acts as a reservoir for generating sphingolipids 
(Linardic and Hannun, 1994; Andrieu et al., 1996; Zhang et al., 
1997). In particular, labeling sphingomyelin in various compart-
ments with 
3H before stimulation and determining the location 
and amount of labeled metabolites (Andrieu et al., 1996) or 
  using subcellular fractionation to locate membranes depleted of 
sphingomyelin (Linardic and Hannun, 1994) both indicate the 
inner leafl  et as the source. The enzyme mainly responsible for 
N-SMase activity outside the CNS, sphingomyelin phosphodi-
esterase 2 (Stoffel et al. 2005), is primarily located in the plasma 
membrane (Karakashian et al. 2004). Furthermore, N-SMase 
activity predominantly occurs in the plasma membrane frac-
tion, and receptor-coupled sphingomyelin degradation has been 
shown to mostly occur at this site (Levade and Jaffrezou, 1999).
The novel technique that we have used, combining prob-
ing with the sphingomyelin binding protein lysenin (for review 
see Kobayashi et al., 2004) with selective sphingomyelin diges-
tion, permits separate microscopic visualization of the dynamics 
of sphingomyelin in either the outer or inner leafl  ets on an indi-
vidual cell basis. Using this method, we show that the inner 
leafl  et of the plasma membrane contains a pool of sphingo-
myelin that can be recruited for signaling during induction of 
myogenic cell proliferation. This reduction in sphingomyelin 
levels in the inner leafl  et in response to CFCS stimulation was 
caused by N-SMase catalyzed cleavage, as the N-SMase inhibitor 
GW4869 (Luberto et al., 2002) both prevented the transient 
drop in sphingomyelin and drastically reduced the number of 
cells entering the cell cycle. These observations strongly indi-
cate that the inner leafl  et is the source of the mitogenic S1P, 
consistent with and extending previous studies (Linardic and 
Hannun, 1994; Andrieu et al., 1996; Zhang et al., 1997).
In conclusion, we demonstrate that sphingolipid signaling 
plays a central role in adult stem cell biology. Upon stimulation, 
sphingomyelin in the inner leafl  et of the plasma membrane is 
cleaved by N-SMase, and subsequent metabolism results in an 
increased level of S1P, which acts as a mitogen for muscle satel-
lite cells. As would be predicted from these observations, inhi-
bition of S1P generation perturbs muscle regeneration. Indeed, 
a recently described mutation in choline kinase β gene, central 
to phospholipid biosynthesis, results in a rapidly progressive 
muscular dystrophy (Sher et al., 2006). Coordinated control of 
satellite cell function is crucial to the regenerative responsive-
ness of muscle both during aging (Conboy et al., 2005) and in 
hereditary myopathies. Lipid signaling potentially offers new 
targets for therapeutic intervention that could augment/restore 
satellite cell function and may well be involved in the control of 
related stem cell systems.JCB • VOLUME 174 • NUMBER 2 • 2006  252
Materials and methods
Cell culture and drug treatment
The C2 (Yaffe and Saxel, 1977) subclone C2C12 was maintained in DME 
containing 20% FCS, 4 mM L-glutamine, 100 U/ml penicillin, and 100 
μg/ml streptomycin at 37°C in 5% CO2. To prepare reserve cells, prolifer-
ating C2C12 cells were switched to DME containing 1% horse serum for 5 d, 
after which few cells were still dividing as shown by BrdU incorporation. 
CFCS was prepared by incubating 10 ml FCS with 1 g of activated 
  charcoal (Sigma-Aldrich) overnight at 4°C before the charcoal was removed 
by centrifugation and ﬁ  ltration. Cells were stimulated with either 0.5–2% 
CFCS or S1P (BIOMOL Research Laboratories, Inc.) in DME containing 
4 mg/ml fatty acid–free BSA (Sigma-Aldrich) for 18 h, and 10 μM BrdU was 
added for 6 h before ﬁ  xation with 4% PFA/PBS. Cells were preincubated 
with inhibitors for 45 min before serum stimulation. DMS (BIOMOL 
  Research Laboratories, Inc.) stock solution was prepared in DMSO and 
used at a ﬁ  nal concentration of 2–10 μM. GW4869 (Calbiochem) was 
stored as a 1.5 mM suspension in DMSO and solubilized by the addition 
of methane sulphonic acid to a ﬁ  nal concentration of 0.25%, immediately 
before use at 10–20 μM. FB1 (BIOMOL Research Laboratories, Inc.) was 
dissolved in distilled water and used at 10–20 μM.
Single-ﬁ  ber isolation and culture
Adult (>8 wk of age) C57Bl/6 or C57B16/DBA2 mice were killed by cervi-
cal dislocation before the extensor digitorum longus muscles were carefully 
removed. Myoﬁ  bers were isolated in DME as described previously (  Rosenblatt 
et al., 1995) and cultured in either DME/BSA or DME with 10% [vol/vol] 
horse serum and 0.5% [vol/vol] CEE [MP Biomedicals]) at 37°C in 5% 
CO2. Drug treatments were performed in the same way as for C2C12 cells, 
except that BrdU was added to the medium from the beginning of culture.
Visualization of sphingomyelin using lysenin
Cells were treated with 100 mU/ml bSMase from Bacillus cereus (Sigma-
Aldrich) for 2 h at 37°C in 5% CO2 either before or after ﬁ  xation with 4% 
PFA. When GW4869 was used, the cells were washed in DME after 
bSMase treatment. Fixed cells were blocked with 0.5% BSA in PBS and in-
cubated with 0.2–10 μg/ml lysenin (provided by S. Kawashima and 
N. Ohta, Zenyaku Kogyo, Tokyo, Japan; Peptide Institute, Inc.) in 0.5% 
BSA in PBS for 1 h. Lysenin was then visualized with an anti-lysenin 
antibody (Peptide Institute, Inc.).
Muscle regeneration
To elicit muscle damage, both TA muscles were injected with 20 μl of the 
snake venom cardiotoxin (Sigma-Aldrich) together with India ink to mark 
the injection site. The right TA also received DMS (1 μmol/kg of body 
weight) dissolved in DMSO, whereas the left served as a control, receiving 
only DMSO. 7 d later, both muscles were removed and cryosectioned, and 
separate sections were analyzed by hematoxylin and eosin staining or 
  immunostaining for eMyHC. The area occupied by regenerating myoﬁ  bers 
was then determined by using Scion Image (Scion Corp.) from several such 
experiments, and the data were pooled and expressed as a percentage 
± SEM of the total area assayed.
Immunostaining
For BrdU detection, ﬁ  xed C2C12 cells or myoﬁ  bers were permeabilized 
with 0.5% (vol/vol) Triton X-100 and treated with 3 N hydrochloric acid 
for 10 min at room temperature. For immunostaining for PCNA, myoﬁ  bers 
were treated with 100% methanol. Frozen sections were ﬁ  xed with 10% 
formalin/PBS for 30 min at room temperature and then autoclaved for 10 min 
in 20 mM Tris-HCl buffer, pH 9.0. After these treatments, samples were 
  incubated for 2 h at room temperature with primary antibodies in 0.5% 
BSA/PBS, followed by ﬂ  uorochrome (Alexaﬂ  uor 488 with Alexaﬂ  uor 594 
or TRITC)–conjugated secondary antibodies (Invitrogen) before mounting 
in Fluoromount ﬂ  uorescent mounting medium (DakoCytomation) containing 
100 ng/ml DAPI. Primary antibodies used were monoclonal rat anti-BrdU 
(clone BU1/75; Abcam), monoclonal mouse anti-PCNA (clone PC10; 
  DakoCytomation), monoclonal Pax7 (Developmental Studies Hybridoma 
Bank), monoclonal eMyHC (clone F1.652; American Type Culture Collection), 
monoclonal MyoD (clone 5.8A; DakoCytomation), polyclonal rabbit 
  anti-lysenin (Peptide Institute, Inc.), and polyclonal MyoD (Santa Cruz 
  Biotechnology, Inc.).
Image capture
Immunostained cells and myoﬁ   bers were viewed on an epiﬂ  uorescence 
  microscope (model Axiophot; Carl Zeiss MicroImaging, Inc.) using 10×/0.30 
Ph1-, 20×/0.50 Ph2-, and 40×/0.75 Ph2-PlanNeoﬂ   uar lenses. Digital 
images were acquired with a charge-coupled device camera (model RTE/
CCD-1300-Y; Princeton Instruments, Inc.) at –10°C using MetaMorph soft-
ware version 4.5r5 (Universal Imaging Corp.). Images were optimized 
globally for contrast and brightness and assembled into ﬁ  gures using 
  Photoshop 7.0.1 (Adobe).
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